Rachel Galot

5PUBLICATIONS
66CO-AUTHORS
Predictive and prognostic markersMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 23, 2026
Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project.

Athénaïs van der Elst, Daniel Herrero-Saboya, Lucas Michon

|Feb 10, 2026
Genomic and Immune Landscape of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Progressing on Anti-PD-1 Treatment.

Athénaïs van der Elst, Daniel Herrero-Saboya, Lucas Michon

|Aug 11, 2025
Tumor-Informed ctDNA Assay to Predict Outcome in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated with PD-1 Inhibitor.

Natasha Honoré, George Laliotis, Vasily N Aushev

|Feb 21, 2025
Safety and Antitumor Activity of a Novel aCD25 Treg Depleter RG6292 as a Single Agent and in Combination with Atezolizumab in Patients with Solid Tumors.

Valentina Gambardella, Michael Ong, Maria E Rodriguez-Ruiz

|Jul 19, 2023
Regression of a melanoma brain metastasis that had appeared after immune checkpoint inhibitor discontinuation: a hypothesis-generating case.

Julien Pierrard, Emmanuel Seront, Rachel Galot

Pageof 1

Frequent Collaborators

4 joint publications

Jean-Pascal Machiels

2 joint publications

Marie Morfouace

2 joint publications

Sylvie Rusakiewicz

2 joint publications

Preethi Devanand